Focus Stocks
Bristol-Myers Squibb to Announce Results for Second Quarter 2012 on July 25
Published on Monday, 02 July 2012 14:30 Written by TradersHuddle Staff
NEW YORK-( Business Wire )-Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the second quarter of 2012 on Wednesday, July 25, 2012. During a conference call at 10:30 a.m. EDT on July 25, company executives will review financial information and will address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing 913-312-0418, confirmation code: 4565698. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 2 p.m. EDT on July 25 through 8 p.m. EDT on August 8, 2012. The replay will also be available through http://investor.bms.com or by dialing 402-280-9013, confirmation code: 4565698.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
Related Articles
- Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
- Critical Alerts For Caterpillar, Bristol-Myers Squibb, F5 Networks, Lear, and Leap Wireless Released By InvestorsObserver
- Former Pro Football Coach Bill Cowher Tells Men "No Excuses" When It Comes To Getting Screened For Melanoma
- Santaris Pharma announces a worldwide discovery alliance with Bristol-Myers Squibb for RNA-targeted medicines
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures
Related Partner Headlines
- Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Laggard - TheStreet.com
- Bristol-Myers Squibb Company Stock Buy Recommendation Reiterated (BMY) - TheStreet.com
- Bristol-Myers Squibb's Investigational Hepatitis C Compounds Lambda and Daclatasvir Plus Ribavirin Achieved SVR12 in 93% of Genotype 1b Treatment-Naive Patients In Phase IIb Study - Benzinga
- UPDATE: BMO Capital Markets Downgrades Bristol-Myers Squibb to Market Perform, Lowers PT - Benzinga
- 'Mad Money' Lightning Round: Buy Nordstrom, Harley-Davidson - TheStreet.com
- New Head-to-Head Patient Reported Outcomes Data for Orencia - Benzinga
- Bristol-Myers Squibb Company (BMY): Today's Featured Health Care Laggard - TheStreet.com
- Bristol-Myers Squibb Receives Positive Decision from NIH for YERVOY - Benzinga
- Bristol-Myers Squibb Company Stock Buy Recommendation Reiterated (BMY) - TheStreet.com
- 5 Bullish Stocks That Will Pay You to Own Them - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
-
Trading Idea: - Is Cognizant Technology Solutions close to Resistance? -
Amgen Is Close to the 50 Day Moving Average -
Trading Idea: Is SAIC Breaking Out? -
Trading Idea: - Is Goodyear close to Resistance? -
CenturyLink Is in a Well Structured Setup -
Juniper Networks Is Close to Resistance -
Deere Is in a Well Defined Range
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,263.36 Trade time:12:32PM EDT Value change:▼31.14 (-0.20%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,644.81 Trade time:12:32PM EDT Value change:▼5.70 (-0.35%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,449.63 Trade time:12:32PM EDT Value change:▼9.79 (-0.28%)In The Wires
-
HRT well helps to confirm Gondwana Gold's Petroleum System Model, offshore Namibia -
Royal Dutch Shell plc: Buyback of Own Shares -
VOXX International Corporation To Participate In The 10th Annual Craig-Hallum Institutional Investor Conference -
Aquasition Corp. Receives Nasdaq Deficiency Notice -
Bunge Announces Annual Meeting Results -
Cushing® Renaissance Fund Announces Quarterly Distribution -
JCP&L Completes Numerous Projects Prior to Summer Season to Enhance Customer Service Reliability -
Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.








